Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for
Macular Edema Secondary to Inflammation
Location: Nashville TN, Carmel IN, St Louis MO, West Columbia SC,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: Nashville TN, Carmel IN, St Louis MO, West Columbia SC,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase3, Recruiting

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

for
Diabetic Macular Edema
Location: Nashville TN, Wake Forest NC, Falls Church VA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07553429

Phase1, Phase2, Recruiting

Suprachoroidal Administration in Subjects With Metastases to the Choroid

for
Eye Cancer, Primary Cancer
Location: Nashville TN, Ann Arbor MI, Bellaire TX, Miami FL,
Sponsor: Aura Biosciences

Sex: All

Age: 18+

Code: NCT06643884

Phase2, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Nashville TN, Greenville SC, Indianapolis IN, Carmel IN,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)

for
Stickler Syndrome Type 1, Stickler Syndrome Type 2
Location: Nashville TN, Birmingham AL, Royal Oak MI, Rochester MN,
Sponsor: Helen Keller Eye Research Foundation

Sex: All

Age: 0+

Code: NCT07146516

Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Nashville TN, Carmel IN, St Louis MO, Madison MS,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase3, Recruiting

Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser

for
Immediate Post-Treatment Care, Aging Mid-Face, Aging
Location: Nashville TN, Sacramento CA
Sponsor: Lynch Regenerative Medicine

Sex: All

Age: 40 - 70

Code: NCT07718347

Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: Nashville TN, Hixson TN, Lexington KY, Atlanta GA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase3, Recruiting

The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF

for
Infertility Primary
Location: Nashville TN, Cincinnati OH, Las Vegas NV
Sponsor: Ovation Fertility

Sex: All

Age: 0+

Code: NCT06521372

Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Nashville TN, Chattanooga TN, Atlanta GA, Cincinnati OH,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05379985

Phase1, Phase2, Recruiting

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

for
B-cell Acute Lymphoblastic Leukemia
Location: Nashville TN, Chicago IL, Madison WI, Buffalo NY,
Sponsor: Cellectis S.A.

Sex: All

Age: 15 - 50

Code: NCT04150497

Phase1, Phase2, Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Nashville TN, Indianapolis IN, Pittsburgh PA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase1, Phase2, Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

for
Metastatic Hepatocellular Carcinoma, Solid Tumors,
Location: Nashville TN, Detroit MI, Westwood KS, Baltimore MD,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06915753

Phase1, Recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

for
Neutropenia
Location: Woodland TX, Atlanta GA, Memphis TN, Cincinnati OH,
Sponsor: X4 Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06056297

Phase3, Recruiting

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

for
Cancer, Melanoma Stage III, Melanoma Stage IV,
Location: Nashville TN, Indianapolis IN, Canton OH, Cleveland OH,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT05970497

Phase1, Phase2, Recruiting

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: The Woodlands TX, Newnan GA, Germantown TN, Edgewood KY,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06588478

Phase2, Recruiting

First In Human Study of CX-2051 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Denver CO, Nashville TN, Huntersville NC, Fairfax VA,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06265688

Phase1, Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for
Cancer, Advanced Cancer, Locally Advanced Carcinoma,
Location: Nashville TN, St Louis MO, Fairfax VA, Sarasota FL,
Sponsor: Angiex, Inc.

Sex: All

Age: 18+

Code: NCT06440005

Phase1, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Nashville TN, Indianapolis IN, Centerville OH,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase3, Recruiting